Literature DB >> 28864418

The expression profiles of circRNAs in lung tissues from rats with lipopolysaccharide-induced acute respiratory distress syndrome: A microarray study.

Qi-Quan Wan1, Di Wu2, Qi-Fa Ye3.   

Abstract

The development of circular RNA (circRNA) microarray has facilitated the study of the role of circRNAs in regulating gene expression through a circRNA-miRNA-mRNA network. In our study, microarray was performed to detect the expression profiles of circRNAs during lipopolysaccharide (LPS)-induced acute respiratory distress syndrome (ARDS). Twenty rats were randomly divided into 2 groups, the control group and the LPS group, 10 rats in each group. Three rats each from both groups were randomly selected. Using circRNA microarray data, we compared the circRNA expression profiles in lung tissues between these 6 rats. The most differentially expressed circRNA species from these profiles were validated and optimized as ARDS biomarkers and potential therapeutic targets. Overall, 395 and 562 circRNAs were significantly up- and down-regulated in LPS group vs. control group, respectively. Six up-regulated and 4 down-regulated circRNAs from the top 10 candidates were eventually selected to be validated. Among them, only 4 up-regulated circRNAs (mmu_circRNA_19423, rno_circRNA_010489, rno_circRNA_011426, mmu_circRNA_30664) and 1 down-regulated circRNA (rno_circRNA_005564) exhibited significant validation. The 5 highest ranking target miRNAs of these 5 validated circRNAs were predicted according to the miRNA support vector regression method. This is the first study to investigate circRNA expression profile and a large number of aberrantly expressed circRNAs were revealed during ARDS. The significantly over- or under-expressed circRNA may represent a novel biomarker and be developed as a novel therapeutic target for the clinical management of ARDS. The results are preliminary and need to be confirmed in further well-designed studies with larger sample size.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ARDS; Circular RNA; Lipopolysaccharide; Microarray

Mesh:

Substances:

Year:  2017        PMID: 28864418     DOI: 10.1016/j.bbrc.2017.08.131

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Candidate Genes as Biomarkers in Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome Based on mRNA Expression Profile by Next-Generation RNA-Seq Analysis.

Authors:  Qi-Quan Wan; Di Wu; Qi-Fa Ye
Journal:  Biomed Res Int       Date:  2018-04-08       Impact factor: 3.411

2.  Microarray expression profile of circular RNAs in lung tissues from rats with lipopolysaccharide-induced acute respiratory distress syndrome.

Authors:  Qiquan Wan; Di Wu; Qifa Ye
Journal:  Data Brief       Date:  2017-10-10

3.  Characteristics of circular RNA expression in lung tissues from mice with hypoxia‑induced pulmonary hypertension.

Authors:  Jian Wang; Meng-Chan Zhu; Bill Kalionis; Jun-Zhen Wu; Lin-Lin Wang; Hai-Yan Ge; Cui-Cui Chen; Xiao-Dan Tang; Yuan-Lin Song; Hong He; Shi-Jin Xia
Journal:  Int J Mol Med       Date:  2018-06-21       Impact factor: 4.101

4.  CircRNA expression profiling and bioinformatics analysis indicate the potential biological role and clinical significance of circRNA in influenza A virus-induced lung injury.

Authors:  Jiajia Wang; Yanbing Zhang; Fengfeng Zhu; Liling Chen; Yao Wei; Qingqing Zhu; Junhong Jiang; Jian -An Huang; Qiang Guo; Xinjing Yang
Journal:  J Biosci       Date:  2021       Impact factor: 1.826

5.  Circ_0038467 regulates lipopolysaccharide-induced inflammatory injury in human bronchial epithelial cells through sponging miR-338-3p.

Authors:  Guangming Liu; Qiufeng Wan; Jingwen Li; Xinying Hu; Xingli Gu; Sicheng Xu
Journal:  Thorac Cancer       Date:  2020-03-17       Impact factor: 3.500

6.  Circular RNAs are abundant and dynamically expressed during the embryonic lung development of C57BL/6 mice.

Authors:  Meng-Jie Zhang; Jiang-Wen Yin; Jin-Huan Wu; Jie Gu; Cai-Yun Yuan; Hong-Jun Miao; Zhang-Bin Yu
Journal:  Heliyon       Date:  2020-03-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.